Arama Sonuçları - Doug Coyle

Cost-Effectiveness of Pharmacological Treatments for Osteoporosis Consistent with the Revised Economic Evaluation Guidelines for Canada Yazar: Doug Coyle

Tam Metin Erişim

Mise en oeuvre d’une politique pour une génération sans tabac au Canada : estimation des répercussions à long terme Yazar: Doug Coyle

Tam Metin Erişim

Considerations when applying equity weights within economic evaluation when making drug reimbursement decisions Yazar: Doug Coyle

Tam Metin Erişim

Implementing a smoke-free generation policy for Canada: estimates of the long-term impacts Yazar: Doug Coyle

Tam Metin Erişim

The Impact of Alternative Specifications of Uncertainty Relating to Extrapolation in Decision Models Yazar: Doug Coyle, Kathryn Coyle

Tam Metin Erişim

A cost-utility analysis of the impact of electronic nicotine delivery systems on health care costs and outcomes in Canada Yazar: Catherine M. Pound, Doug Coyle

Tam Metin Erişim

Analyse coût-utilité de l’incidence des inhalateurs électroniques de nicotine sur les coûts et les résultats des soins de santé au Canada Yazar: Catherine M. Pound, Doug Coyle

Tam Metin Erişim

What guidance are researchers given on how to present network meta-analyses to end-users such as policymakers and clinicians? A systematic review. Yazar: Shannon M Sullivan, Doug Coyle, George Wells

Tam Metin Erişim

Economic evaluation of HIV testing options for low-prevalence high-income countries: a systematic review Yazar: Olanrewaju Medu, Adegboyega Lawal, Doug Coyle, Kevin Pottie

Tam Metin Erişim

Population health value of being in target: Results from the Canadian Multi-Morbidity Model for Type 2 Diabetes Yazar: Ian Sobotka, Lauren Cipriano, Doug Coyle, Deva Thiruchelvam, Baiju Shah

Tam Metin Erişim

Cost-Effectiveness of Colchicine for Recurrent Cardiovascular Events Yazar: Kevin E. Boczar, MD, Rob Beanlands, MD, George Wells, Doug Coyle

Tam Metin Erişim

When piloting health services interventions, what predicts real world behaviours? A systematic concept mapping review Yazar: Tavis Hayes, Natasha Hudek, Ian D. Graham, Doug Coyle, Jamie C. Brehaut

Tam Metin Erişim

A technique for approximating transition rates from published survival analyses Yazar: Markian A. Pahuta, Joel Werier, Eugene K. Wai, Roy A. Patchell, Doug Coyle

Tam Metin Erişim

A Bayesian meta-analysis of multiple treatment comparisons of systemic regimens for advanced pancreatic cancer. Yazar: Kelvin Chan, Keya Shah, Kelly Lien, Doug Coyle, Henry Lam, Yoo-Joung Ko

Tam Metin Erişim

Cost-effectiveness of integrated disease management for high risk, exacerbation prone, patients with chronic obstructive pulmonary disease in a primary care setting Yazar: Andrew D. Scarffe, Christopher J. Licskai, Madonna Ferrone, Kevin Brand, Kednapa Thavorn, Doug Coyle

Tam Metin Erişim

Phase-Based and Lifetime Health System Costs of Care for Patients Diagnosed with Leukemia and Lymphoma: A Population-Based Descriptive Study Yazar: Anubhav Agarwal, Natasha Kekre, Harold Atkins, Haris Imsirovic, Brian Hutton, Doug Coyle, Kednapa Thavorn

Tam Metin Erişim

Cost-Effectiveness of Canakinumab From a Canadian Perspective for Recurrent Cardiovascular Events Yazar: Kevin E. Boczar, MD, Rob Beanlands, MD, George Wells, PhD, Doug Coyle, PhD

Tam Metin Erişim

Cost-effectiveness of cannabinoids for pediatric drug-resistant epilepsy: protocol for a systematic review of economic evaluations Yazar: Jesse Elliott, Bláthnaid McCoy, Tammy Clifford, Beth K. Potter, Becky Skidmore, George A. Wells, Doug Coyle

Tam Metin Erişim

Cost Effectiveness of Infant Vaccination for Rotavirus in Canada Yazar: Doug Coyle, Kathryn Coyle, Julie A Bettinger, Scott A Halperin, Wendy Vaudry, David W Scheifele, Nicole Le Saux

Tam Metin Erişim

Protocol for a modelling study to assess the clinical and cost-effectiveness of indefinite anticoagulant therapy for first unprovoked venous thromboembolism Yazar: Marc Rodger, Grégoire Le Gal, Kednapa Thavorn, Faizan Khan, Tobias Tritschler, Dean Fergusson, Doug Coyle, Sasha van Katwyk

Tam Metin Erişim